Investigating the Use of Prolia (Denosumab) in the Treatment of Acute Charcot Neuroarthropathy

NCT03174366 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Charcot Joint of Foot

Interventions

DRUG: Denosumab

Sponsor

Western University of Health Sciences